期刊文献+

5-Aza-CdR和TSA联合调控乳腺癌maspin基因表达的研究 被引量:1

Combination of 5-Aza-CdR and trichostatin A on cell proliferation and maspin gene expression in breast cancer cell line MDA-MB-435S
下载PDF
导出
摘要 目的:研究5-氮-2′-脱氧胞苷(5-A-za-CdR)和曲古菌素A(TSA)对乳腺癌MDA-MB-435S细胞增殖及抑癌基因maspin表达的影响。方法:用特异性甲基转移酶抑制剂5-Aza-CdR和组蛋白去乙酰酶抑制剂TSA分别单独和联合作用MDA-M-B-435S乳腺癌细胞株5~8d,用MTT比色法观察细胞在药物作用前后的生长活性;RT-PCR检测细胞作用前后maspin mRNA的表达。结果:5μmol/L5-Aza-CdR作用乳腺癌细胞株MDA-MB-435S8d后,与对照组比较能明显抑制肿瘤细胞的生长;不同浓度TSA作用该细胞5d后,在>100ng/mL浓度时才能显著的抑制该细胞的增殖。RT-PCR显示,5-Aza-CdR和TSA联合作用时可显著的诱导maspin mRNA的重新表达;而两药单用时其诱导作用相对较弱。结论:在人乳腺癌MDA-MB-435S细胞中,maspin基因可能因表观遗传改变而导致转录失活,maspin基因的重新表达能有效的抑制细胞生长。5-Aza-CdR和TSA可作为乳腺癌治疗的新方向。 OBJECTIVE: To investigate the effects of 5-Aza-2'-deoxycytidine (5-Aza-CdR) and trichostatin A (TSA) on the proliferation of MDA-MB-435S cells and the expression of tumor suppressor gene maspin. METHODS: Human breast cancer cell line MDA-MB-435S was treated with either 5 μmol/L 5-Aza-CdR (a specific demethylating agent) or different concentrations of TSA (a specific histone deacetylase inhibitor) for 5 to 8 days. The growth of MDA-MB-435S cells was observed by MTT assay. The expression of maspin mRNA was observed by reverse transcription-polymerase chain reaction (RT-PCR) before and after 5-Aza-CdR and/or TSA treatment. RESULTS: MDA-MB-435S cells treated with 5-Aza-CdR displayed a slowed growth in comparison with the control cells. TSA significantly inhibited the proliferation of the same cancer cell at 100 ng/mL, maspin mRNA was re-expressed in MDA-MB-435S cells after 5-Aza-CdR and/or TSA treatment. Moreover, the combination of the two drugs significantly induced the re-expression of maspin mRNA compared with the single drug alone. CONCLUSIONS: maspin gene might be transcriptional silencing by abnormal epigenetic changes and the re-expression of maspin gene by 5-Aza-CdR/TSA can inhibit the proliferation of MDA-M-B-435S breast cancer cells. It suggests that 5-Aza-CdR/TSA may be a potential therapeutic agent in the treatment of breast cancer.
出处 《中华肿瘤防治杂志》 CAS 2008年第10期725-728,共4页 Chinese Journal of Cancer Prevention and Treatment
基金 国家自然科学基金(30400432)
关键词 乳腺肿瘤 脱氧胞苷 羟肟酸类 基因 肿瘤抑制 breast neoplasms deoxycytidine hydroxamic acids genes, tumor suppressor
  • 相关文献

参考文献15

  • 1Lockett J,Yin S,Li X,et al.Tumor suppressive maspin and epithelial homeostasis[J].J Cell Biochem,2006,97(4):651-660.
  • 2Oliveira A M,Ross J S,Fletcher J A.Tumor suppressor genes in breast cancer:the gatekeepers and the caretakers[J].Am J Clin Pathol,2005,124(Suppl):S16-S28.
  • 3Herranz M,Esteller M.DNA methylation and histone modifications in patients with cancer:potential prognostic and therapeutic targets[J].Methods Mol Biol,2007,361:25-62.
  • 4DAlessio A C,Szyf M.Epigenetic tete-a-tete:the bilateral relationship between chromatin modifications and DNA methylation[J].Biochem Cell Biol,2006,84(4):463-476.
  • 5Saito Y,Jones P A.Epigenetic activation of tumor suppressor microRNAs in human cancer cells[J].Cell Cycle,2006,5(19):2220-2222.
  • 6任婕,魏敏杰,金锋,杨栋,林哲珠,马文峰,金万宝.散发性乳腺癌组织中BRCA1基因启动子甲基化与蛋白表达的相关性[J].中华肿瘤防治杂志,2007,14(3):161-164. 被引量:12
  • 7毕高峰,刘佳宁,温培娥,杨炜华,任霞,唐天华,谢超,董伟,姜国胜.曲古抑菌素A促进As_2O_3诱导HL-60细胞分化与分子机制的研究[J].中华肿瘤防治杂志,2007,14(9):653-656. 被引量:9
  • 8Villar-Garea A,Imhof A.The analysis of histone modification[J].Biochim Biophys Acta,2006,1764(12):1932-1939.
  • 9Garcia-Manero G,Issa J P.Histone deacetylase inhibitors:a review of their clinical status as antineoplastic agents[J].Cancer Invest,2005,23(7):635-642.
  • 10Mai A,Massa S,Rotili D,et al.Histone deacetylation in epigenetics:an attractive target for anticancer therapy[J].Med Res Rev,2005,25(3):261-309.

二级参考文献14

  • 1邵晓轶,沈爱国,程纯.Cyclin D3与肿瘤的研究进展[J].实用癌症杂志,2004,19(4):440-442. 被引量:5
  • 2Giuseppe ZARDO,Francesco FAZI,Lorena TRAVAGLINI,Clara NERVI.Dynamic and reversibility of heterochromatic gene silencing in human dis-ease[J].Cell Research,2005,15(9):679-690. 被引量:5
  • 3Monneret C.Histone deacetylase inhibitors[J].Eur J Med Chem,2005,40(1):1-13.
  • 4Kouzarides T.Histone acetylases and deacetylases in cell proliferation[J].Curr Opin Genet Dev,1999,9(1):40-48.
  • 5Redner R I,Wang J,Liu J M.Chromatin remodeling and leukemia:new therapeutic paradigms[J].Blood,1999,94(2):417-428.
  • 6Rosato R R,Almenara J A,Grant S.The histone deacetylase inhibitor MS-275 promotes differentiation or apoptosis in human leukemia cells through a process regulated by generation of reactive oxygen species and induction of p21CIP1/WAF1[J].Cancer Res,2003,63(13):3637-3645.
  • 7Hess-Stumpp H.Histone deacetylase inhibitors and cancer:from cell biology to the clinic[J].Eur J Cell boil,2005,84(2-3):109-121.
  • 8Dokmanovic M,Marks P A.Prospects:histone deacetylase inhibitors[J].J Cell Biochem,2005,96(2):293-304.
  • 9Marks P A,Richon V M,Rifkind R A.Histone Deacetylase Inhibitors:inducers of differentiation of apoptosis of transformed cells[J].J Natl Cancer Inst,2000,92(15):1210-1216.
  • 10Kosugi H,Towatari M,Hatano S,et al.Histone deacetylase inhibitors are the potent inducer/enhancer of differentiation in acute myeloid leukemia:a new approach to anti-leukemia therapy[J].Leukemia,1999,13(9):1316-1324.

共引文献19

同被引文献12

  • 1Zou Z, Anisowicz A, Hendrix M J,et al. Maspin,a serpin with tumor-suppressing activity in human mammary epithelial cells [J]. Science,1994,263(5146):526-529.
  • 2Maass N, Teffner M, Rosel F,et al. Decline in the expression of the serine proteinase inhibitor maspin is assoeiated with turnout peogression in ductal carcinomas of the bteast[J]. J Pathol, 2001,195(3) :321-326.
  • 3Dokras A, Gardner L M, Kirschmann D A,et al. The tumour suppressor gene maspin is differentially rrgulated in cytotrophoblasts during human placental development[J]. Placenta, 2002, 23(4) : 274-280.
  • 4Song S Y, Lee S K, Kim D H, et al. Expression of maspin in colon cancers: its relationbhip with p53 expression and micerovessel density[J]. Dig Dis Sci,2002,47(8):1831-1835.
  • 5Chen Z, Fan Z, Mc NeaalJ E, et al. Hepsin and maspin are inversely expressed in laser capture microdissectioned prostate cancer [J].Urol,2003,169(4):1316-1319.
  • 6Ito R, Nakayama H, Yoshida K, et al. Loss of Maspin expression is associated with developpmen and progression of gastric carcinoma with P53 abnormality[J]. Oncol Rep, 2004, 12 (5) : 985- 990.
  • 7Liu J,Yin S,Reddy N, et al. Bax mediates the apoptosis sensitizing effect of maspin[J]. Cancer Rcs,2004,10(5) :634-637.
  • 8Antonello A, Romani, Paolo Soliani, et al. The associated expression of maspin and Pax proteine as a proteins as a potential prognostic factor in intrahepatic cholangiocarcinma[J]. BMC Cancer,2006,6(4): 255-262
  • 9Xu C, Quddus M R, Sung C J, et al. Maspin expression in CIN 3, microinvasive s quamous cell carcinoma, and invasive squamous cell carcinoma of the uterine cervix[J]. Mod Pathol, 2005, 18(8) : 1102-1106.
  • 10Bubendorf L,Dalquen P, Foerster J, et al. Nuclear and cytoplasmic Maspin expression in primary non-small cell lung cancer[J]. Jounmal of clinical pathology,2007,60(5):483-486.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部